Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

RecruitingOBSERVATIONAL
Enrollment

1,020

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Thymic Epithelial TumorThymic CarcinomaThymomaThymoma and Thymic Carcinoma
Interventions
DIAGNOSTIC_TEST

Artificial Intelligence Diagnostics

AI Diagnostics uses advanced algorithms for precise histological image analysis to help diagnose disease, including subtype.

DIAGNOSTIC_TEST

Recurrence Prediction Tool

This AI tool evaluates thymic tumour data and other clinical data and calculates the risk of recurrence, with the aim of analysing whether there is an association with specific subtypes of thymic epithelial tumours and clinical data.

Trial Locations (1)

3015 GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Maastro Clinic, The Netherlands

OTHER

collaborator

Hospices Civils de Lyon

OTHER

lead

Erasmus Medical Center

OTHER